Answers are grounded in this paper and cite their sources.
Demonstrates improved stability and properties of microencapsulated EBN co-products, indicating potential for functional food uses.
[4,3] of 6.14 ± 0.14 µm, narrow size distribution (span 1.33 ± 0.01), low moisture content, high solubility, and 1.7-fold higher sialic acid retention than non-encapsulated EBNCH. These findings demonstrate an effective strategy to valorise EBN co-products for functional food and nutraceutical applications.
No takes yet. Share an insight, caveat, or question.
Salleh et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: